These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 36824451)

  • 21. Procoagulant phenotype of virus-infected pericytes is associated with portal thrombosis and intrapulmonary vascular dilations in fatal COVID-19.
    Cadamuro M; Lasagni A; Radu CM; Calistri A; Pilan M; Valle C; Bonaffini PA; Vitiello A; Toffanin S; Venturin C; Friòn-Herrera Y; Sironi S; Alessio MG; Previtali G; Seghezzi M; Gianatti A; Strazzabosco M; Strain AJ; Campello E; Spiezia L; Palù G; Frigo AC; Tosoni A; Nebuloni M; Parolin C; Sonzogni A; Simioni P; Fabris L
    J Hepatol; 2024 Jun; ():. PubMed ID: 38908437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary microvascular dysfunction pathophysiology in COVID-19.
    Yin J; Wang S; Liu Y; Chen J; Li D; Xu T
    Microcirculation; 2021 Oct; 28(7):e12718. PubMed ID: 34013612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recovery of Endothelium-dependent vascular relaxation impairment in convalescent COVID-19 patients: Insight from a pilot study.
    Gouzi F; Philippe A; Pastre J; Renaud B; Gendron N; Subileau M; Hua-Huy T; Planquette B; Sanchez O; Smadja DM; Günther S
    Respir Med Res; 2023 Nov; 84():101044. PubMed ID: 37625374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comprehensive review of vascular complications in COVID-19.
    Acharya Y; Alameer A; Calpin G; Alkhattab M; Sultan S
    J Thromb Thrombolysis; 2022 Apr; 53(3):586-593. PubMed ID: 34724155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long COVID: pathophysiological factors and abnormalities of coagulation.
    Turner S; Khan MA; Putrino D; Woodcock A; Kell DB; Pretorius E
    Trends Endocrinol Metab; 2023 Jun; 34(6):321-344. PubMed ID: 37080828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
    Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
    mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy.
    Chang JC
    Vasc Health Risk Manag; 2021; 17():273-298. PubMed ID: 34103921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial injury exacerbates coronavirus disease 2019: The role of endothelial glycocalyx protection.
    Okada H; Yoshida S; Hara A; Ogura S; Tomita H
    Microcirculation; 2021 Apr; 28(3):e12654. PubMed ID: 32791568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Damage to endothelial barriers and its contribution to long COVID.
    Wu X; Xiang M; Jing H; Wang C; Novakovic VA; Shi J
    Angiogenesis; 2024 Feb; 27(1):5-22. PubMed ID: 37103631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications.
    Nägele MP; Haubner B; Tanner FC; Ruschitzka F; Flammer AJ
    Atherosclerosis; 2020 Dec; 314():58-62. PubMed ID: 33161318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab.
    Rambaldi A; Gritti G; Micò MC; Frigeni M; Borleri G; Salvi A; Landi F; Pavoni C; Sonzogni A; Gianatti A; Binda F; Fagiuoli S; Di Marco F; Lorini L; Remuzzi G; Whitaker S; Demopulos G
    Immunobiology; 2020 Nov; 225(6):152001. PubMed ID: 32943233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-leukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis?
    Ghasemzadeh M; Ahmadi J; Hosseini E
    Thromb Res; 2022 May; 213():179-194. PubMed ID: 35397313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity-Related Inflammation and Endothelial Dysfunction in COVID-19: Impact on Disease Severity.
    De Lorenzo A; Estato V; Castro-Faria-Neto HC; Tibirica E
    J Inflamm Res; 2021; 14():2267-2276. PubMed ID: 34079332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The COVID-19 Pandemic: Disproportionate Thrombotic Tendency and Management Recommendations.
    Karim S; Islam A; Rafiq S; Laher I
    Trop Med Infect Dis; 2021 Feb; 6(1):. PubMed ID: 33670475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute respiratory distress syndrome.
    Galvin IM; Steel A; Pinto R; Ferguson ND; Davies MW
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD003707. PubMed ID: 23881653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiological mechanisms of thrombosis in acute and long COVID-19.
    Jing H; Wu X; Xiang M; Liu L; Novakovic VA; Shi J
    Front Immunol; 2022; 13():992384. PubMed ID: 36466841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombotic risk in children with COVID-19 infection: A systematic review of the literature.
    Zaffanello M; Piacentini G; Nosetti L; Ganzarolli S; Franchini M
    Thromb Res; 2021 Sep; 205():92-98. PubMed ID: 34293539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.